Back to search
FDAFDA · Food and drugs·Recall number D-0591-2025

Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.

Published August 27, 2025 · Recall initiated: August 4, 2025

Summary

FDA records drug Class II recall D-0591-2025, published August 27, 2025 and initiated August 4, 2025. Recalling firm: PFIZER INC; Status: Ongoing; Reported quantity: 15,750 vials; Lot: Lot #: LH2671, Exp. 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM BICARBONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM BICARBONATE
Manufacturer
PFIZER INC
Distributor
U.S. Nationwide
Lot
Lot #: LH2671, Exp. 11/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14. recalled?

Yes. FDA published recall D-0591-2025 on August 27, 2025. Reported hazard: Lack of Assurance of Sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM BICARBONATE.